×
Please click
here
if you are not redirected within a few seconds.
All
Images
Videos
Maps
News
Shopping
Books
Search tools
Any time
Any time
Past hour
Past 24 hours
Past week
Past month
Past year
All results
All results
Verbatim
Did you mean:
revision dekra milano
Milano - Google Business
g.page › revisionidekramilano › share
No information is available for this page. ·
Learn why
Ivosidenib in IDH1-mutant, chemotherapy-refractory ... - PubMed
pubmed.ncbi.nlm.nih.gov › ...
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
People also search for
Ivosidenib
NCT02989857
ClarIDHy trial
Ivosidenib cholangiocarcinoma FDA approval
NCT02074839
NCT02150967